195 related articles for article (PubMed ID: 35505353)
41. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
SCORE2-OP working group and ESC Cardiovascular risk collaboration
Eur Heart J; 2021 Jul; 42(25):2455-2467. PubMed ID: 34120185
[TBL] [Abstract][Full Text] [Related]
42. Predictive value of lung function measures for cardiovascular risk: a large prospective cohort study.
Zhou L; Yang H; Zhang Y; Wang Y; Zhou X; Liu T; Yang Q; Wang Y
Thorax; 2024 Feb; 79(3):250-258. PubMed ID: 38050152
[TBL] [Abstract][Full Text] [Related]
43. Do the 2017 blood pressure cut-offs improve 10-year cardiovascular disease mortality risk prediction?
Peng Y; Wang Z
Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):2008-2016. PubMed ID: 32723581
[TBL] [Abstract][Full Text] [Related]
44. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
Al-Shamsi S; Govender RD; King J
BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
[TBL] [Abstract][Full Text] [Related]
45. Development and validation of multicentre study on novel Artificial Intelligence-based Cardiovascular Risk Score (AICVD).
Jalepalli SK; Gupta P; Dekker ALAJ; Bermejo I; Kar S
Fam Med Community Health; 2024 Jan; 12(Suppl 1):. PubMed ID: 38238156
[TBL] [Abstract][Full Text] [Related]
46. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions.
LIFE-CVD2 Working Group
Eur J Prev Cardiol; 2024 May; ():. PubMed ID: 38752762
[TBL] [Abstract][Full Text] [Related]
47. Do population-level risk prediction models that use routinely collected health data reliably predict individual risks?
Li Y; Sperrin M; Belmonte M; Pate A; Ashcroft DM; van Staa TP
Sci Rep; 2019 Aug; 9(1):11222. PubMed ID: 31375726
[TBL] [Abstract][Full Text] [Related]
48. Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus.
Zhu L; Singh M; Lele S; Sahakian L; Grossman J; Hahn B; McMahon M
Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35193947
[TBL] [Abstract][Full Text] [Related]
49. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran.
Fahimfar N; Fotouhi A; Mansournia MA; Malekzadeh R; Sarrafzadegan N; Azizi F; Mansourian M; Sepanlou SG; Emamian MH; Hadaegh F; Roohafza H; Hashemi H; Poustchi H; Pourshams A; Samavat T; Sharafkhah M; Talaei M; Van Klaveren D; Steyerberg EW; Khalili D
Int J Health Policy Manag; 2022 Feb; 11(2):210-217. PubMed ID: 32668896
[TBL] [Abstract][Full Text] [Related]
50. The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthrit.
Salaffi F; Carotti M; Di Carlo M; Tardella M; Lato V; Becciolini A; Favalli EG; Giovagnoni A
Swiss Med Wkly; 2018 Aug; 148():w14656. PubMed ID: 30141517
[TBL] [Abstract][Full Text] [Related]
51. Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients.
Curtis JR; Xie F; Crowson CS; Sasso EH; Hitraya E; Chin CL; Bamford RD; Ben-Shachar R; Gutin A; Flake DD; Mabey B; Lanchbury JS
Arthritis Res Ther; 2020 Dec; 22(1):282. PubMed ID: 33276814
[TBL] [Abstract][Full Text] [Related]
52. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.
Ridker PM; Buring JE; Rifai N; Cook NR
JAMA; 2007 Feb; 297(6):611-9. PubMed ID: 17299196
[TBL] [Abstract][Full Text] [Related]
53. How do cardiovascular risk prediction equations developed among 30-74 year olds perform in older age groups? A validation study in 125 000 people aged 75-89 years.
Mehta S; Jackson R; Poppe K; Kerr AJ; Pylypchuk R; Wells S
J Epidemiol Community Health; 2020 Jun; 74(6):527-533. PubMed ID: 32144211
[TBL] [Abstract][Full Text] [Related]
54. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
[TBL] [Abstract][Full Text] [Related]
55. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
56. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
[TBL] [Abstract][Full Text] [Related]
57. Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into coronary heart disease (CHD) and stroke.
van Kempen BJ; Ferket BS; Kavousi M; Leening MJ; Steyerberg EW; Ikram MA; Witteman JC; Hofman A; Franco OH; Hunink MG
Int J Cardiol; 2014 Feb; 171(3):413-8. PubMed ID: 24438922
[TBL] [Abstract][Full Text] [Related]
58. Determining cardiovascular risk in patients with unattributed chest pain in UK primary care: an electronic health record study.
Jordan KP; Rathod-Mistry T; van der Windt DA; Bailey J; Chen Y; Clarson L; Denaxas S; Hayward RA; Hemingway H; Kyriacou T; Mamas MA
Eur J Prev Cardiol; 2023 Aug; 30(11):1151-1161. PubMed ID: 36895179
[TBL] [Abstract][Full Text] [Related]
59. Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study.
Hippisley-Cox J; Coupland C
BMJ Open; 2015 Sep; 5(9):e008503. PubMed ID: 26353872
[TBL] [Abstract][Full Text] [Related]
60. QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus.
Edwards N; Langford-Smith AWW; Parker BJ; Bruce IN; Reynolds JA; Alexander MY; McCarthy EM; Wilkinson FL
Lupus Sci Med; 2018; 5(1):e000272. PubMed ID: 30167314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
